Resources from the same session
490MO - Patient-reported outcomes of first-line selpercatinib versus chemotherapy with or without pembrolizumab in RET fusion-positive advanced non-small cell lung cancer: Interim analysis of LIBRETTO-431
Presenter: Koichi Goto
Session: Mini oral session 2: Thoracic cancer
Resources:
Abstract
Slides
Webcast
518MO - TROPION-Lung05: Datopotamab deruxtecan (Dato-DXd) in previously treated non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGAs)
Presenter: Satoru Kitazono
Session: Mini oral session 2: Thoracic cancer
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mini oral session 2: Thoracic cancer
Resources:
Webcast